about
Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid TumoursMolecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrappingPerspectives and limitations of microarray-based gene expression profiling of thyroid tumors.Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.Drug safety evaluation of lenvatinib for thyroid cancer.Efficacy of lenvatinib in treating thyroid cancer.The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice.Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study.Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.Has differentiated thyroid cancer (DTC) staging changed with in the last ten years in the Silesia region of Poland?Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.[Indications for surgery of thyroid cancer based on bioptate molecular examination].[Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?][Diagnosis and treatment of thyroid cancer - Polish guidelines].[Completion total thyroidectomy in children with differentiated thyroid cancer][Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi][Relapse of differentiated thyroid carcinoma in low-risk patients][Gene expression analysis by DNA microarray in papillary thyroid cancer][Clinical course and treatment of patients with differentiated thyroid carcinoma diagnosed during the year 1995]
P50
Q30313129-20B1B575-95A7-4E85-A810-06460A7D8B53Q31141133-FF943FD9-22BC-466B-9706-4288A3F5343BQ36410621-E43C119A-B9D8-457C-9997-1118C6134185Q36757987-B92F3A0F-7BA8-4DD8-A397-9595A9F641FBQ36834614-AED42644-A226-4DBE-9207-109C67D04C34Q38612008-E0D1D520-B494-4006-9D7D-258161A6AAA1Q38843403-C56EB3B1-3E80-4887-8FC1-5E0B31D27770Q40627041-A7099748-46EE-4081-ABF4-0E30F51AD219Q44674311-128485B2-98B7-4477-A165-894F653E65ACQ50016120-6E2AB01F-F317-4A3D-8162-A3F99B78EB02Q51745039-324F2F86-8D86-4196-BC11-0D885717B5B2Q53173047-7B28D260-5C9B-4351-A734-25847F7DC38BQ54579058-75D17391-0C94-4B57-ADBF-66FBACC71469Q57221765-C7610D05-0997-4457-95EC-6FF5D79C12A2Q62065571-A7B1EA55-353B-4323-9F71-15370C369EC2Q79152043-44CD17DB-5F7D-4347-BAC6-17A66BA36BF4Q79152055-4A3353A4-4959-4474-817E-07F5CF914E42Q79152060-073CA5F8-6D63-43F3-878E-BD4191782B1CQ79830386-6EA6DD34-1FD9-445F-A4E4-4DEC5038A805Q79830388-9A0AB0BE-6BD4-4BEF-83D5-9AD08BA5988B
P50
description
Forscher
@de
Pools onderzoekster
@nl
investigador
@es
researcher
@en
ricercatore
@it
研究員
@ja
研究者
@zh
name
Aleksandra Kukulska
@ast
Aleksandra Kukulska
@ca
Aleksandra Kukulska
@cs
Aleksandra Kukulska
@en
Aleksandra Kukulska
@es
Aleksandra Kukulska
@gl
Aleksandra Kukulska
@hr
Aleksandra Kukulska
@hsb
Aleksandra Kukulska
@it
Aleksandra Kukulska
@nl
type
label
Aleksandra Kukulska
@ast
Aleksandra Kukulska
@ca
Aleksandra Kukulska
@cs
Aleksandra Kukulska
@en
Aleksandra Kukulska
@es
Aleksandra Kukulska
@gl
Aleksandra Kukulska
@hr
Aleksandra Kukulska
@hsb
Aleksandra Kukulska
@it
Aleksandra Kukulska
@nl
prefLabel
Aleksandra Kukulska
@ast
Aleksandra Kukulska
@ca
Aleksandra Kukulska
@cs
Aleksandra Kukulska
@en
Aleksandra Kukulska
@es
Aleksandra Kukulska
@gl
Aleksandra Kukulska
@hr
Aleksandra Kukulska
@hsb
Aleksandra Kukulska
@it
Aleksandra Kukulska
@nl
P106
P1412
P1559
Aleksandra Kukulska
@pl
P21
P27
P31
P3124
P496
0000-0002-4909-9190